Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.83+0.03 (+0.15%)
Close on Nov 13, 2026Market cap $936.90MP/E –Yield –
Silence Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Silence Therapeutics's enterprise value was $861.96M on Nov 11, 2026, against $216.16M a year earlier. Over the last 5 years it ranged from -$14.13M to $940.22M, with a median of $341.57M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $861.96M | +366.0% |
| 2025 | Dec 31, 2025 | $184.99M | -9.2% |
| 2024 | Dec 31, 2024 | $203.77M | -67.4% |
| 2023 | Dec 29, 2023 | $624.21M | +38.0% |
| 2022 | Dec 30, 2022 | $452.16M | -30.6% |
| 2021 | Dec 31, 2021 | $651.18M | +18.2% |
| 2020 | Dec 31, 2020 | $550.93M | – |
See a number that looks wrong?